Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Miriam M. Kraemer"'
Autor:
Theodora Tsimpaki, Nikolaos E. Bechrakis, Berthold Seitz, Miriam M. Kraemer, Hongtao Liu, Sami Dalbah, Ekaterina Sokolenko, Utta Berchner-Pfannschmidt, Miltiadis Fiorentzis
Publikováno v:
Cancers
Volume 15
Issue 5
Pages: 1436
Volume 15
Issue 5
Pages: 1436
OA Förderung 2023 Background: Patient-derived tumor xenografts (PDXs) have emerged as valuable preclinical in vivo models in oncology as they largely retain the polygenomic architecture of the human tumors from which they originate. Although animal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4729c95a4d035cc96f9db0666496daa3
Autor:
Lina S. Farhoumand, Miltiadis Fiorentzis, Miriam M. Kraemer, Ali Sak, Martin Stuschke, Tienush Rassaf, Ulrike Hendgen-Cotta, Nikolaos E. Bechrakis, Utta Berchner-Pfannschmidt
Publikováno v:
Cancers; Volume 14; Issue 13; Pages: 3097
Uveal melanoma (UM) is the most common intraocular tumor in adults. Despite local tumor control, no effective therapy has been found to prevent metastasis, resulting in a high mortality rate. In the present study, we evaluated the anti-tumor potentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cc2f584ea7019cacb61d3a08d9f521b
https://duepublico2.uni-due.de/servlets/MCRFileNodeServlet/duepublico_derivate_00076530/cancers_2022-14-03097.pdf
https://duepublico2.uni-due.de/servlets/MCRFileNodeServlet/duepublico_derivate_00076530/cancers_2022-14-03097.pdf
Autor:
Miriam M. Kraemer, Theodora Tsimpaki, Utta Berchner-Pfannschmidt, Nikolaos E. Bechrakis, Berthold Seitz, Miltiadis Fiorentzis
Publikováno v:
Cancers; Volume 14; Issue 12; Pages: 2889
Electrochemotherapy (ECT) is the combination of transient pore formation following electric pulse application with the administration of cytotoxic drugs, which enhances the cytotoxic effect of the applied agent due to membrane changes and permeabiliz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4720eb61eaeffc53d8bed6fe20d69c78
https://pubmed.ncbi.nlm.nih.gov/35740554
https://pubmed.ncbi.nlm.nih.gov/35740554
Autor:
Vinodh Kakkassery, Timo Gemoll, Miriam M. Kraemer, Thorben Sauer, Aysegül Tura, Mahdy Ranjbar, Salvatore Grisanti, Stephanie C. Joachim, Stefan Mergler, Jacqueline Reinhard
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 7; Pages: 4058
Chemotherapy resistance is one of the reasons for eye loss in patients with retinoblastoma (RB). RB chemotherapy resistance has been studied in different cell culture models, such as WERI-RB1. In addition, chemotherapy-resistant RB subclones, such as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98b003548187ad6ef49d8081711987ac
https://pubmed.ncbi.nlm.nih.gov/35409416
https://pubmed.ncbi.nlm.nih.gov/35409416